No significant fault

The International Tennis Integrity Agency: The International Tennis Integrity Agency (ITIA) on Thursday confirmed that World No.1 woman player Iga Swiatek of Poland has accepted a one-month suspension under the Tennis Anti-Doping programme for testing positive for a prohibited substance. Swiatek has tested positive for the prohibited substance trimetazidine (TMZ) and was provisionally suspended from September 12, 2024. She successfully appealed against the verdict and got the period reduced, thus missing three tournaments.

The ITIA has accepted that the prohibited substance was because of a contaminated regulated medication, which results in a "No Significant Fault or Negligence finding", thus handing a one-month suspension.

"The International Tennis Integrity Agency (ITIA) today confirms that Iga Swiatek, a 23-year-old tennis player from Poland, has accepted a one-month suspension under the Tennis Anti-Doping Programme, after testing positive for the prohibited substance trimetazidine (TMZ) in an out-of-competition sample in August 2024," the ITIA informed in a statement on Thursday.